And by the way- it is a FACT that SVFC is currently being courted by several big biotechs. My money is on a partnership with a particular Big European Biotech. ;) In Europe the process is growing even faster than in the US. SVFC is THE future of medicine. The 500 million dollar deal Cytori just received in China...will be small beans in comparison to where SVFC is headed! SVFC's Intellicell process has shown to be superior to Cytori's IN EVERY SINGLE WAY!!! :)
Lol! Maybe I was not clear enough...a hypothesis is a "proposed explanation"...that is why they call it a "hypothesis". http://en.wikipedia.org/wiki/Hypothesis
I also said, " If EFH had any major relevance in the stock market then the term "undervalued" would not exist",
I never said undervalued was proven...just hope that is clear.
I recall previous posts insisting that the O/S was 1.5bil, but the last filing shows this not to be the case...just keeping it real here. For clarification the A/S is 1.5 bil, the O/S is 300mil.
Imo, need to realize SVFC is an emerging, start up biotech that has developments underway offering significant advantages for long term success and attaining a competitive advantage in the marketplace. FYI, SVFC has only been in business for slightly over two years and with a PPS at subpenny is very undervalued. I would rather invest now, than wait until the PPS is over $2.
News 
Market Data 
Discover 
AI
